Affluense AI AFFLUENSE

🔓 Unlock the full profile of Jayakumar Ramamoorthy (Eywa), including verified contact details, financial insights, and professional associations.

See Jayakumar Ramamoorthy Full Profile

Below are the ✅ Verified Contact Details to help you connect directly:

Email: jay*****@eyw******.com

Mobile: 96864*****

Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)

Key Insights You Should Know About This Individual
  • Jayakumar Ramamoorthy is the Co-Founder of Eywa Pharma, which was established in April 2015, focusing on pharmaceutical innovation and development.
  • Prior to founding Eywa Pharma, Ramamoorthy served as the Promoter-Director of Valugen Pharma from July 2012 until November 2014, contributing to the growth and market presence of the company.
  • Ramamoorthy held multiple leadership positions at Mylan, where roles included Vice President of Global Business Development - Portfolio Licensing, Vice President of EMEA Tech Ops, and Vice President of Sourcing & BD across an extensive tenure from December 2010 to March 2010.
  • In their role at Mylan, Ramamoorthy was instrumental in strategizing for business development and operational management, significantly impacting the company's international footprint.
  • Before joining Mylan, Ramamoorthy was associated with Matrix Laboratories Limited as Associate Vice President - API BD from January 2000 to January 2007, focusing on active pharmaceutical ingredient business development.
  • Ramamoorthy began their career in the pharmaceutical industry at Pfizer Ltd as a Professional Service Officer from November 1991 until November 1993, gaining foundational experience in the field.
  • Jayakumar Ramamoorthy also worked at Nestle India Limited as a Medical Detailing Officer from November 1993 until April 2000, contributing to the enhancement of medical communications strategies.
  • The diverse roles and experiences across various pharmaceutical organizations have equipped Ramamoorthy with substantial expertise in business development, operational excellence, and strategic planning in the healthcare sector.